Investors
Investment themes
Orexo is driving growth through its US commercial presence, innovative AmorphOX technology, and expanding pipeline. By leveraging these strengths, we aim to address unmet medical needs and explore new partnerships beyond our core focus on opioid use disorder.
Presentations at Carnegie March 12-13 2025
Financial key performance indicators
Latest report
Sustainability achievements 2024
>90%
Revenues in 2024 related to SDG 3.5 (prevent and treat substance abuse)
100%
Completion of Code of Conduct training
100%
Supplier for commercial supply have sustainability processes in place
8 out of 10
Are satisfied working at Orexo